Linnea is arguably, by virtue of its "botanic"and parent heritage with Ipsen (Major French Pharma US$8bn) + Schwabe (Major Swiss and German Pharma), has the best partner for Europe. What a market.
And Linnea exports to over 70 countries as well.
At $14m mkt cap, I bet the $100-$150m mkt cap MM companies like MMJ, MDC, MXC and AC8 would love this European partner. Huge value to be realised. Very impressed.
Some big days ahead.
GG